FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094012 [Registered on: 01/09/2025] Trial Registered Prospectively
Last Modified On: 01/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparative Clinical Study To Evaluate The Efficacy Of Tila Kwatha Gandusha And Triphala (Bibhitaki Aamlaki Haritaki) Kwatha Gandusha In Mukhapaka With Special Reference To Stomatitis  
Scientific Title of Study   Comparative Clinical Study To Evaluate The Efficacy Of Tila Kwatha Gandusha And Triphala Kwatha Gandusha In Mukhapaka With Special Reference To Stomatitis  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Teaswini Suresh Makode 
Designation  Pg Scholar 
Affiliation  SVNHT Ayurved Mahavidyalaya And Chikitsalaya, Shrishivajinagar Rahuri Factory 
Address  Department of Shalakyatantra SVNHT Ayurved Mahavidyalaya And Chikitsalaya Shrishivajinagar Rahuri Factory Maharashtra India 413706

Ahmadnagar
MAHARASHTRA
413706
India 
Phone  8830215455  
Fax    
Email  makodetejal@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sandee Nimase  
Designation  Associate Professor  
Affiliation  SVNHT Ayurved Mahavidyalaya And Chikitsalaya,Shrishivajinagar Rahuri Factory 
Address  Department of Shalakyatantra SVNHT Ayurved Mahavidyalaya And Chikitsalaya Shrishivajinagar Rahuri Factory Maharashtra India 413706

Ahmadnagar
MAHARASHTRA
413706
India 
Phone  8421534177  
Fax    
Email  snimase85@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Tejaswini Suresh Makode 
Designation  Pg Scholar 
Affiliation  SVNHT Ayurved Mahavidyalaya And Chikitsalaya,Shrishivajinagar Rahuri Factory 
Address  Department of Shalakyatantra, SVNHT Ayurved Mahavidyalaya And Chikitsalaya, Shrishivajinagar Rahuri Factory,Maharashtra,India

Ahmadnagar
MAHARASHTRA
413706
India 
Phone  8830215455  
Fax    
Email  makodetejal@gmail.com  
 
Source of Monetary or Material Support  
Department Of Shalakyatantra, SVNH Ayurved Mahavidyalaya And Chikitsalaya, Shrishivajinagar Rahuri Factory, 413706 Maharashtra, India. 
 
Primary Sponsor  
Name  Dr Tejaswini Suresh Makode 
Address  Department Of Shalakyatantra SVNHT Ayurved Mahavidyalaya And Chikitsalaya Shrishivajinagar Rahuri Factory 413706 Maharashtra India 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Tejaswini Suresh Makode  SVNHT Ayurved Mahavidyalaya And Chikitsalaya Shrishivajinagar Rahuri Factory   Department Of SVNHT Ayurved Mahavidyalaya And Chikitsalaya Shrishivajinagar Rahuri Factory Maharashtra India 413706
Ahmadnagar
MAHARASHTRA 
8830215455

makodetejal@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ETHICAL COMMITTEE OF SVNH AYURVED MAHAVIDYALAYA AND CHIKITSALAYA RAHURI FACTORY 413706  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K137||Other and unspecified lesions of oral mucosa. Ayurveda Condition: MUKHAROGAH, (2) ICD-10 Condition:R52||Pain, unspecified. Ayurveda Condition: MUKHAROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Tila Kwatha Gandusha , Reference: Pandit suryaprasad Tripathi Bhaishajya Ratnavali satik kaviraj pandit gopalprasad Sharma kaushik prakashan Mumbai shloka no 62 page no 812, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: Madhu), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Triphala Kwatha Gandusha, Reference: Aacharya Trivedi Astang Sangrah Uttarsthan Adhyay no 26 sholka no 164, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: Madhu), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients having Lakshana of Mukhapaka
Patients with age group of 18-60 years
Patients willing for trial with written consent
Patients having recurrent Mukhapaka
 
 
ExclusionCriteria 
Details  unconscious, poisoned, weak, krisha person,
patient suffering from bleeding disorders
Patient having chronic or carcinogenic ulcers in oral cavity
Patient age below 18 years and above 60 years
Patients suffering from any other systemic disorder Patients with oral candidiasis
Patients with diagnosed oral malignancy
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To compare the EFFICACY OF

TILA KWATHA GANDUSHA AND TRIPHALA KWATHA GANDUSHA
IN MUKHAPAKA


 
30 days



IN MUKHAPAKA
 
 
Secondary Outcome  
Outcome  TimePoints 
TO EVALUATE THE EFFICACY OF
TILA KWATHA GANDUSHA
IN MUKHAPAKA  
At the end of
30 DAYS 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   13/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A consecutive samples of 60 patients who are seeking treatment and care at the study hospital
 who fullfil the eligibility (inclusion and exclusion) criteria and who consent to participant will be selected by convenience sampling method from the study setting (ie. the OPD/Ward/Hospital)
 The sample will be then randomly and equally allocated to two groups
The selected sample of 60 subjects will be randomly allocated to two groups using Simple block randomization method
 A predetermined computer generated random allocation plan will be utilised where in 15 blocks of size 4 each will be used for equal assignment of subjects in to two comparison groups
First group will recieve  TILA KWATHA GANDUSHA and second group will recieve TRIPHALA KWATHA GANDUSHA  
 
Close